May 18, 2011 (Montreal, Quebec) — Brain and spinal cord atrophy in patients with multiple sclerosis (MS) correlates with the phenotype of the disease and the degree of disability, according to 2 ...
Dec. 3, 2003 (Chicago) — Neuronal cell death in multiple sclerosis (MS) occurs prior to the hallmark brain atrophy, according to findings presented here at the 89th annual meeting of the Radiological ...
Magnetic resonance imaging measurements of atrophy in an important area of the brain are an accurate predictor of multiple sclerosis (MS), according to a new study. According to the researchers, these ...
A study published in the journal Radiology has found that lower susceptibility in the thalamic and higher susceptibility in the basal ganglia, measured using quantitative susceptibility mapping, was ...
BUFFALO, N.Y. – For people with multiple sclerosis (MS), hearing a doctor tell them they are experiencing brain atrophy—an important, predictive biomarker of MS disease progression—can trigger ...
For people with multiple sclerosis (MS), hearing a doctor tell them they are experiencing brain atrophy — an important, predictive biomarker of MS disease progression — can trigger debilitating fear ...
The treatment landscape for multiple sclerosis (MS) has seen extensive growth over the last several decades. While the field still lacks universally accepted, algorithm-based treatment guidelines for ...
Please provide your email address to receive an email when new articles are posted on . WEST PALM BEACH, Fla. — Spinal cord atrophy appeared to predict silent progression in relapse-onset MS, ...
A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability ...
Multiple sclerosis (MS) is commonly regarded as an inflammatory disease, but it also has a neurodegenerative component, which represents an additional target for treatment. The use of MRI to evaluate ...
(HealthDay News) – Use of magnetic resonance imaging (MRI) biomarkers may identify patients who are at high risk for conversion from clinically isolated syndrome (CIS) to clinically definite multiple ...